Sheila Dewitt
Principal investigator, leads DeuteRx LLC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$589KFederal grants as PI2 awards
5Patents grantedLatest Nov 21, 2023
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $589K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 2, 2016 | NIH | SBIR Phase I Stabilized Prasugrel enantiomers for pediatric sickle cell disease | $295K | DeuteRx LLC |
| Sep 1, 2016 | NIH | SBIR Phase I Stabilized Prasugrel enantiomers for pediatric sickle cell disease | $295K | DeuteRx LLC |
6 patents as inventor
- US 10555946DeuteRx LLCFeb 11, 2020
- US 11040925DeuteRx LLCJun 22, 2021
- US 11491156DeuteRx LLCNov 8, 2022
- US 11535603DeuteRx LLCDec 27, 2022
- US 11820720DeuteRx LLCNov 21, 2023
- US DeuteRx LLC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#2,273
Awards as PI#1,252
Patents#25
Companies
- DeuteRx LLCLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.